A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers

被引:18
|
作者
Ding, Yuan C. [1 ,70 ]
McGuffog, Lesley [2 ]
Healey, Sue [5 ]
Friedman, Eitan [6 ,7 ,8 ]
Laitman, Yael [6 ,7 ,8 ]
Shani-Paluch-Shimon [6 ,7 ,8 ]
Kaufman, Bella [6 ,7 ,8 ]
Liljegren, Annelie [9 ]
Lindblom, Annika [10 ]
Olsson, Hakan [11 ]
Kristoffersson, Ulf [12 ]
Stenmark-Askmalm, Marie [13 ]
Melin, Beatrice [14 ]
Domchek, Susan M. [15 ]
Nathanson, Katherine L. [15 ]
Rebbeck, Timothy R. [15 ]
Jakubowska, Anna [17 ]
Lubinski, Jan [17 ]
Jaworska, Katarzyna [17 ]
Durda, Katarzyna [17 ]
Gronwald, Jacek [17 ]
Huzarski, Tomasz [17 ]
Cybulski, Cezary [17 ]
Byrski, Tomasz [17 ]
Osorio, Ana [18 ,19 ,20 ]
Ramony Cajal, Teresa [21 ]
Stavropoulou, Alexandra V. [24 ]
Benitez, Javier [18 ,19 ,20 ]
Hamann, Ute [25 ]
Rookus, Matti [26 ]
Aalfs, Cora M. [27 ]
de Lange, Judith L. [26 ]
Meijers-Heijboer, Hanne E. J. [28 ]
Oosterwijk, Jan C. [131 ]
van Asperen, Christi J. [132 ]
Garcia, Encarna B. Gomez [133 ,134 ]
Hoogerbrugge, Nicoline [135 ]
Jager, Agnes [136 ]
van der Luijt, Rob B. [137 ]
Easton, Douglas F. [3 ]
Peock, Susan [3 ]
Frost, Debra [3 ]
Ellis, Steve D. [3 ]
Platte, Radka [3 ]
Fineberg, Elena [3 ]
Evans, D. Gareth [29 ]
Lalloo, Fiona [29 ]
Izatt, Louise [30 ]
Eeles, Ros [31 ,32 ]
Adlard, Julian [33 ]
机构
[1] Beckman Res Inst City Hope, Dept Populat Sci, 1500 East Duarte Rd, Duarte, CA 91010 USA
[2] Univ Cambridge Worts Causeway, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge, England
[3] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Cambridge, England
[4] Univ Cambridge, Dept Med Genet, Cambridge, England
[5] Royal Brisbane Hosp, Queensland Inst Med Res, Genet & Populat Hlth Div, Brisbane, Qld 4029, Australia
[6] Chaim Sheba Med Ctr, Oncogenet Unit, IL-52621 Tel Hashomer, Israel
[7] Chaim Sheba Med Ctr, Inst Oncol, IL-52621 Tel Hashomer, Israel
[8] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel
[9] Karolinska Univ Hosp, Dept Oncol, Stockholm, Sweden
[10] Karolinska Univ Hosp, Dept Clin Genet, Stockholm, Sweden
[11] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden
[12] Univ Lund Hosp, Dept Clin Genet, S-22185 Lund, Sweden
[13] Linkoping Univ, Dept Clin & Expt Med, Div Clin Genet, Linkoping, Sweden
[14] Umea Univ, Dept Radiat Sci, Umea, Sweden
[15] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA
[16] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[17] Pomeranian Med Univ, Dept Genet & Pathol, Szczecin, Poland
[18] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Human Genet Grp, Madrid, Spain
[19] Spanish Natl Canc Res Ctr, Human Canc Genet Programme, Genotyping Unit, Madrid, Spain
[20] Spanish Network Rare Dis CIBERER, Barcelona, Spain
[21] Hosp Santa Creu & Sant Pau, Oncol Serv, Barcelona, Spain
[22] Inst Catala Oncol, Lab Recerca Translac, Hereditary Canc Program, Mol Diagnost Unit, Barcelona, Spain
[23] IDIBELL Catalan Inst Oncol, Hereditary Canc Program, Genet Counseling Unit, Barcelona, Spain
[24] Natl Ctr Sci Res Demokritos, IRRP, Mol Diagnost Lab, Athens, Greece
[25] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany
[26] Netherlands Canc Inst, Dept Epidemiol, Amsterdam, Netherlands
[27] Univ Amsterdam, Acad Med Ctr, Dept Clin Genet, NL-1105 AZ Amsterdam, Netherlands
[28] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Amsterdam, Netherlands
[29] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England
[30] Guys & St Thomas NHS Fdn Trust, London, England
[31] Inst Canc Res, Oncogenet Team, London SW36JB, England
[32] Royal Marsden NHS Fdn Trust, London, England
[33] Yorkshire Reg Genet Serv, Leeds, W Yorkshire, England
[34] Yorkhill Hosp, Ferguson Smith Ctr Clin Genet, Glasgow, Lanark, Scotland
[35] Univ Hosp Southampton NHS Fdn Trust, Wessex Clin Genet Serv, Southampton, Hants, England
[36] Birmingham Womens Hosp Healthcare NHS Trust, W Midlands Reg Genet Serv, Birmingham, W Midlands, England
[37] Sheffield Childrens Hosp, Sheffield Clin Genet Serv, Sheffield, S Yorkshire, England
[38] Royal Devon & Exeter Hosp, Dept Clin Genet, Exeter EX2 5DW, Devon, England
[39] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66103 USA
[40] Inst Curie, Dept Tumour Biol, Paris, France
[41] Inst Curie, Unite INSERM U830, Paris, France
[42] Univ Paris 05, Fac Med, Paris, France
[43] CHU Grenoble, Dept Genet, F-38043 Grenoble, France
[44] Univ Grenoble, Inst Albert Bonniot, Grenoble, France
[45] Univ Lyon 1, CNRS, UMR5286, Ctr Rech Cancerol Lyon,INSERM,U1052, F-69365 Lyon, France
[46] Ctr Hosp Univ Lyon, Ctr Leon Berard, Unite Mixte Genet Constitut Canc Frequents, Lyon, France
[47] CHU Besancon, Serv Genet Biol Histol Biol Dev & Reprod, F-25030 Besancon, France
[48] Nancy Univ, Ctr Hosp Reg & Univ, Med Genet Lab, Vandoeuvre Les Nancy, France
[49] Ctr Francois Baclesse, F-14021 Caen, France
[50] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA
基金
澳大利亚国家健康与医学研究理事会; 英国医学研究理事会; 芬兰科学院; 俄罗斯基础研究基金会; 加拿大健康研究院; 美国国家卫生研究院;
关键词
AMINO-ACID POLYMORPHISM; GROWTH-FACTOR-I; GENETIC-VARIATION; INSULIN; RECEPTOR; EXPRESSION; IGF; PROTEINS; FAMILY; AXIS;
D O I
10.1158/1055-9965.EPI-12-0229
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: We previously reported significant associations between genetic variants in insulin receptor substrate 1 (IRS1) and breast cancer risk in women carrying BRCA1 mutations. The objectives of this study were to investigate whether the IRS1 variants modified ovarian cancer risk and were associated with breast cancer risk in a larger cohort of BRCA1 and BRCA2 mutation carriers. Methods: IRS1 rs1801123, rs1330645, and rs1801278 were genotyped in samples from 36 centers in the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Data were analyzed by a retrospective cohort approach modeling the associations with breast and ovarian cancer risks simultaneously. Analyses were stratified by BRCA1 and BRCA2 status and mutation class in BRCA1 carriers. Results: Rs1801278 (Gly972Arg) was associated with ovarian cancer risk for both BRCA1 (HR, 1.43; 95% confidence interval (CI), 1.06-1.92; P = 0.019) and BRCA2 mutation carriers (HR, 2.21; 95% CI, 1.39-3.52, P = 0.0008). For BRCA1 mutation carriers, the breast cancer risk was higher in carriers with class II mutations than class I mutations (class II HR, 1.86; 95% CI, 1.28-2.70; class I HR, 0.86; 95%CI, 0.69-1.09; P-difference, 0.0006). Rs13306465 was associated with ovarian cancer risk in BRCA1 class II mutation carriers (HR, 2.42; P = 0.03). Conclusion: The IRS1 Gly972Arg single-nucleotide polymorphism, which affects insulin-like growth factor and insulin signaling, modifies ovarian cancer risk in BRCA1 and BRCA2 mutation carriers and breast cancer risk in BRCA1 class II mutation carriers. Impact: These findings may prove useful for risk prediction for breast and ovarian cancers in BRCA1 and BRCA2 mutation carriers. Cancer Epidemiol Biomarkers Prev; 21(8); 1362-70. (C)2012 AACR.
引用
收藏
页码:1362 / 1370
页数:9
相关论文
共 50 条
  • [41] Clinical Characteristics and Exploratory Genomic Analyses of Germline BRCA1 or BRCA2 Mutations in Breast Cancer
    Park, Sehhoon
    Lee, Eunjin
    Park, Seri
    Lee, Sohee
    Nam, Seok Jin
    Kim, Seok Won
    Lee, Jeong Eon
    Yu, Jong-Han
    Kim, Ji-Yeon
    Ahn, Jin Seok
    Im, Young-Hyuck
    Park, Woong-Yang
    Park, Kyunghee
    Park, Yeon Hee
    MOLECULAR CANCER RESEARCH, 2020, 18 (09) : 1315 - 1325
  • [42] BRCA1 and BRCA2 deficient tumour models generate distinct ovarian tumour microenvironments and differential responses to therapy
    Boroujeni, Salar Farokhi
    Rodriguez, Galaxia
    Galpin, Kristianne
    Yakubovich, Edward
    Murshed, Humaira
    Ibrahim, Dalia
    Asif, Sara
    Vanderhyden, Barbara C.
    JOURNAL OF OVARIAN RESEARCH, 2023, 16 (01)
  • [43] A novel crosstalk between BRCA1 and sirtuin 1 in ovarian cancer
    Li, Da
    Bi, Fang-Fang
    Chen, Na-Na
    Cao, Ji-Min
    Sun, Wu-Ping
    Zhou, Yi-Ming
    Li, Chun-Yan
    Yang, Qing
    SCIENTIFIC REPORTS, 2014, 4
  • [44] Talking across generations: Family communication about BRCA1 and BRCA2 genetic cancer risk
    Young, Alison Luk
    Butow, Phyllis N.
    Rhodes, Paul
    Tucker, Katherine M.
    Williams, Rachel
    Healey, Emma
    Wakefield, Claire E.
    JOURNAL OF GENETIC COUNSELING, 2019, 28 (03) : 516 - 532
  • [45] Pathologic Features and Immunophenotype of Estrogen Receptor-positive Breast Cancers in BRCA1 Mutation Carriers
    Kaplan, Jennifer S.
    Schnitt, Stuart J.
    Collins, Laura C.
    Wang, Yihong
    Garber, Judy E.
    Montgomery, Kelli
    West, Robert B.
    Krag, Karen
    Fetten, Katharina
    Lincoln, Anne
    Tung, Nadine M.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2012, 36 (10) : 1483 - 1488
  • [46] Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers
    Ogony, Joshua
    Hoskin, Tanya L.
    Stallings-Mann, Melody
    Winham, Stacey
    Brahmbhatt, Rushin
    Arshad, Muhammad Asad
    Kannan, Nagarajan
    Pena, Alvaro
    Allers, Teresa
    Brown, Alyssa
    Sherman, Mark E.
    Visscher, Daniel W.
    Knutson, Keith L.
    Radisky, Derek C.
    Degnim, Amy C.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 197 (02) : 277 - 285
  • [47] Methylation Status and Immunohistochemistry of BRCA1 in Epithelial Ovarian Cancer
    Pradjatmo, Heru
    Dasuki, Djaswadi
    Anwar, Mohammad
    Mubarika, Sofia
    Harijadi
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) : 9479 - 9485
  • [48] Synchronous Ovarian and Breast Cancers with a Novel Variant in BRCA2 Gene: A Case Report
    Llinas-Quintero, Nestor
    Cabrera-Florez, Eduardo
    Mendoza-Fandino, Gustavo
    Matute-Turizo, Gustavo
    Vasquez-Trespalacios, Elsa M.
    Gallon-Villegas, Luis J.
    CASE REPORTS IN ONCOLOGICAL MEDICINE, 2019, 2019
  • [49] BRCA1 gene-related hereditary susceptibility to breast and ovarian cancer in Latvia
    Tihomirova, Laima
    Vaivade, Iveta
    Fokina, Oksana
    Peculis, Raitis
    Mandrika, Ilona
    Sinicka, Olga
    Stengrevics, Aivars
    Krilova, Anna
    Keire, Guntars
    Petrevics, Janis
    Eglitis, Janis
    Timofejevs, Mihails
    Leja, Marcis
    ADVANCES IN MEDICAL SCIENCES, 2014, 59 (01): : 114 - 119
  • [50] Genomic Alterations in Histopathologically Normal Breast Tissue from BRCA1 Mutation Carriers May be Caused by BRCA1 Haploinsufficiency
    Rennstam, Karin
    Ringberg, Anita
    Cunliffe, Heather E.
    Olsson, Hakan
    Landberg, Goeran
    Hedenfalk, Ingrid
    GENES CHROMOSOMES & CANCER, 2010, 49 (01) : 78 - 90